GLP-1 and suicidal thoughts: reviewed, no link found, still monitor
In 2023, a safety signal raised the question of whether GLP-1 medicines such as semaglutide and liraglutide might be linked to suicidal thoughts or self-harm. Regulators took it seriously: Europe's medicines agency reviewed the evidence and closed the signal in April 2024, and large real-world studies have not found a causal link. This guide gives the honest picture and explains why mood monitoring still matters.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.
Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.